Clinical Trial: A HR20031 BE Study on Healthy Subjects
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Type 2 Diabetes
Study Type: Interventional
Official Title: A Bioequivalence Study of HR20031 Tablet in Healthy Subjects
Brief Summary:
The purpose of this study is to assess the bioequivalence between HR20031 FDC tablet and co-administration of SHR3824 tablets, SP2086 tablets and metformin XR tablets.
Read more